EnglishУкраїнська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    Bidzilya P.

    LEFT VENTRICLE FUNCTIONAL STATE IN CHRONIC HEART FAILURE ON THE BACKGROUND OF EXCESS WEIGHT, DEPENDING ON THE LEVEL OF TOTAL CHOLESTEROL AND TRIGLYCERIDES


    About the author: Bidzilya P.
    Heading CLINICAL MEDICINE
    Type of article Scentific article
    Annotation One of the main links in the pathogenesis of development and progression of chronic heart failure (CHF) is a violation of the functional state of the myocardium and lipid metabolism. More and more studies show paradoxical changes in lipid metabolism in patients with CHF, which manifests the worst course and outcome of the disease at a lower concentration of lipids. On the other hand high cholesterol is accompanied by better survival of patients with CHF of both ischemic and non-ischemic genesis. Such changes are called "the paradox of lipids" or "cholesterol paradox". Overweight and obesity are independent risk factors for development and progression of CHF too, but is also well known that a high body mass index (BMI) is associated with reduced mortality – the "obesity paradox". Recently a limited number of studies that examine the influence of lipid content on the functional state of the myocardium in CHF, the further spread of overweight and obesity, which makes the chosen direction of research, timely and relevant. Research objective: To study the left ventricle (LV) functional state in CHF on the background of excess weight, depending on the level of total cholesterol (TCL) and triglycerides (TG). Material and methods: 220 patients were examined and analyzed 76 case histories of patients of with CHF of I–III functional class on the background of overweight and obesity I–III degree. The diagnosis of CHF installed according to WHO criteria, the European society of cardiology and the Association of cardiologists of Ukraine, FC classified according to functional classification of New York Heart Association (NYHA). Etiologic factors of CHF were chronic forms of IHD, arterial hypertension, and/or a combination of both. Using the BMI was found normal, overweight, and the degree of abdominal type of obesity. Biochemical method was used to determine the blood levels of TCL and TG. With doppler-echocardiography the functional state of LV investigated. Results: It is established that a lower TCL and TG are accompanied by a higher functional class of CHF, distribution and deepening of LV systolic dysfunction and pulmonary hypertension. Significant differences in indices of LV diastolic function, depending on the level of TCL and TG was not observed. At high TG levels availability of significant prevalence of speed of late diastolic filling simultaneously with no significant lower ratio of speed of early and late diastolic filling confirms the trend towards a more profound manifestations of LV diastolic dysfunction. Conclusions: Lower values of TCL and TG in patients with CHF on the background of overweight and obesity are associated with more impaired LV functional state.
    Tags chronic heart failure, functional myocardial state, excess weight, lipids level
    Bibliography
    • Voronkov L. G. Rekomendatsiyi z diagnostiki ta likuvannya hronichnoyi sertsevoyi nedostatnosti Asotsiatsiyi kardIologIv Ukrayini ta Ukrayinskoyi asotsiatsiyi fahivtsiv iz sertsevoyi nedostatnosti (2012) / L.G. Voronkov [i dr.] // Ukrayinskiy kardiologichniy zhurnal. – 2013. – No.1 (Dodatok). – S. 6–44.
    • Shepel R. N. «Paradoks holesterina» u patsientov s hronicheskoy serdechnoy nedostatochnostyu / R. N. Shepel // Meditsinskiy sovet – 2016. – No.13. – S. 61-65.
    • Ambale-Venkatesh B. et al. Diastolic function assessed fromtagged MRI predicts heart failure and atrial fibrillation over an 8-year follow-up period: themulti-ethnic study of atherosclerosis / B. Ambale-Venkatesh et al // Eur. Heart J. – 2014. – Vol. 15. P. 442–449.
    • 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure / Р. Ponikowski, A. Voors, S. Anker [et al.] // Eur Heart J. – 2016. – Vol. 37 (27). – Р. 2129–2200.
    • Güder G. Reverse epidemiology in systolic and nonsystolic heart failure: cumulative prognostic benefit of classical cardiovascular risk factors / G. Güder [et al.] ]// Circ. Heart. Fail. – 2009. – Vol. 2 (6). – P. 563-571.
    • Zhang S. Efficacy of statin therapy in chronic systolic cardiac insufficiency: a meta-analysis / S. Zhang [et al.] // Eur. J. Intern. Med. – 2011. – Vol. 22. – P. 478–484.
    • Strandberg T.E. Lipid-lowering drugs and heart failure: where do we go after the statin trials? / T.E. Strandberg // Curr. Opin. Cardiol. – 2010. – Vol. 25. – P. 385–393.
    • De Gennaro L. Statin therapy in heart failure: for good, for bad, or indifferent? / L. De Gennaro [et al.] // Curr. Atheroscler. Rep. – 2014. – Vol. 16: - P. 377.
    • Silva S. et al. Statin-induced low cholesterol is not associated with poor outcome in chronic heart failure / S. Silva et al. // J. Cardiovasc. Pharmacol. Ther. – 2012. – Vol. 17. – P. 284–290.
    • Elmadbouh I. Atorvastatin improves cardiac function and remodeling in chronic non-ischemic heart failure: A clinical and pre-clinical study / I. Elmadbouh [et al.] // The Egyptian Heart Journal. – 2015. – Vol. 67. – P. 289–292.
    • Kjekshus J. Rosuvastatin in older patients with systolic heart failure / J. Kjekshus [et al.] // N. Engl. J. Med. – 2007. – Vol. 357. – P. 2248–2261.
    • Gissi H.F.I. Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-con-trolled trial / H.F.I. Gissi [et al.] // Lancet. – 2008. – Vol. 372. – P. 1231–1239.
    • Takano H. Effects of pitavastatin in Japanese patients with chronic heart failure: the Pitavastatin Heart Failure Study (PEARL Study) / H. Takano [et al.] // Circ. J. – 2013. – Vol. 77. – P. 917–925.
    • Tavazzi L. Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial / L. Tavazzi [et al.] // Lancet. – 2008. – Vol. 372. – P. 1231–1239.
    • Arena R. Influence of Etiology of Heart Failure on the Obesity Paradox / R. Arena // Am. J. Cardiol. – 2009. - Vol. 104 (8). – P. 1116–1121.
    • Cheng Y. Relationship between lipids levels and right ventricular volume overload in congestive heart failure / Y. Cheng [et al.] // Journal of Geriatric Cardiology. – 2014. – Vol. 11. – P. 192-199.
    Publication of the article «World of Medicine and Biology» №4(58), 2016 year, 012-016 pages, index UDK 616.124.2-092:616.12-008.46-036-056.257:[547.922-547.426.23]